Conmed Stock Performance
| CNMD Stock | USD 42.91 1.29 2.92% |
The firm shows a Beta (market volatility) of 1.01, which signifies a somewhat significant risk relative to the market. CONMED returns are very sensitive to returns on the market. As the market goes up or down, CONMED is expected to follow. CONMED now shows a risk of 2.35%. Please confirm CONMED skewness, and the relationship between the treynor ratio and daily balance of power , to decide if CONMED will be following its price patterns.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days CONMED has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound primary indicators, CONMED is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
Actual Historical Performance (%)
One Day Return (2.92) | Five Day Return 4.53 | Year To Date Return 5.9 | Ten Year Return 8.03 | All Time Return 12.6 K |
Forward Dividend Yield 0.0181 | Payout Ratio | Last Split Factor 3:2 | Forward Dividend Rate 0.8 | Dividend Date 2025-10-03 |
1 | Disposition of 2164 shares by Todd Garner of CONMED at 44.0 subject to Rule 16b-3 | 10/31/2025 |
2 | Conmed Corp Q3 2025 Earnings Call Highlights Strong Sales Growth Amidst Margin Challenges | 11/06/2025 |
3 | The Bull Case For CONMED Could Change Following Buyback Launch and Dividend Suspension | 11/14/2025 |
4 | Are Investors Undervaluing CONMED Right Now | 12/02/2025 |
5 | Conmed to exit gastroenterology business | 12/08/2025 |
6 | Is CONMED Now Undervalued After a 40 percent Share Price Drop | 12/09/2025 |
7 | Heres Why Conmed is a Strong Growth Stock | 12/15/2025 |
8 | CONMED Valuation Review as It Exits Gastroenterology and Refocuses on Core Growth Areas | 12/17/2025 |
9 | Insider Trading | 12/31/2025 |
10 | Acquisition by David Bronson of 479 shares of CONMED subject to Rule 16b-3 | 01/02/2026 |
11 | CONMED Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference | 01/05/2026 |
12 | What Is CONMED Corporations Share Price Doing - | 01/07/2026 |
13 | Is CONMEDs CFO Transition and Reaffirmed Guidance Quietly Reframing Its Management Credibility Story | 01/09/2026 |
| Begin Period Cash Flow | 24.3 M | |
| Total Cashflows From Investing Activities | -13.1 M |
CONMED Relative Risk vs. Return Landscape
If you would invest 4,340 in CONMED on October 12, 2025 and sell it today you would lose (49.00) from holding CONMED or give up 1.13% of portfolio value over 90 days. CONMED is currently generating 0.0091% in daily expected returns and assumes 2.3456% risk (volatility on return distribution) over the 90 days horizon. In different words, 21% of stocks are less volatile than CONMED, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
CONMED Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for CONMED's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as CONMED, and traders can use it to determine the average amount a CONMED's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0039
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CNMD |
Based on monthly moving average CONMED is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of CONMED by adding CONMED to a well-diversified portfolio.
CONMED Fundamentals Growth
CONMED Stock prices reflect investors' perceptions of the future prospects and financial health of CONMED, and CONMED fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on CONMED Stock performance.
| Return On Equity | 0.066 | ||||
| Return On Asset | 0.0415 | ||||
| Profit Margin | 0.05 % | ||||
| Operating Margin | 0.11 % | ||||
| Current Valuation | 2.18 B | ||||
| Shares Outstanding | 30.97 M | ||||
| Price To Earning | 188.03 X | ||||
| Price To Book | 1.36 X | ||||
| Price To Sales | 0.99 X | ||||
| Revenue | 1.31 B | ||||
| Gross Profit | 761.13 M | ||||
| EBITDA | 272.18 M | ||||
| Net Income | 132.42 M | ||||
| Cash And Equivalents | 33.35 M | ||||
| Cash Per Share | 1.09 X | ||||
| Total Debt | 905.78 M | ||||
| Debt To Equity | 1.45 % | ||||
| Current Ratio | 2.75 X | ||||
| Book Value Per Share | 32.57 X | ||||
| Cash Flow From Operations | 166.97 M | ||||
| Earnings Per Share | 2.05 X | ||||
| Market Capitalization | 1.33 B | ||||
| Total Asset | 2.31 B | ||||
| Retained Earnings | 560.28 M | ||||
| Working Capital | 361.88 M | ||||
| Current Asset | 393.34 M | ||||
| Current Liabilities | 119.72 M | ||||
About CONMED Performance
By analyzing CONMED's fundamental ratios, stakeholders can gain valuable insights into CONMED's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if CONMED has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if CONMED has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 198.43 | 137.98 | |
| Return On Tangible Assets | 0.17 | 0.18 | |
| Return On Capital Employed | 0.11 | 0.10 | |
| Return On Assets | 0.07 | 0.04 | |
| Return On Equity | 0.16 | 0.17 |
Things to note about CONMED performance evaluation
Checking the ongoing alerts about CONMED for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for CONMED help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| CONMED is unlikely to experience financial distress in the next 2 years | |
| Over 99.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from simplywall.st: Is CONMEDs CFO Transition and Reaffirmed Guidance Quietly Reframing Its Management Credibility Story |
- Analyzing CONMED's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether CONMED's stock is overvalued or undervalued compared to its peers.
- Examining CONMED's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating CONMED's management team can have a significant impact on its success or failure. Reviewing the track record and experience of CONMED's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of CONMED's stock. These opinions can provide insight into CONMED's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for CONMED Stock analysis
When running CONMED's price analysis, check to measure CONMED's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CONMED is operating at the current time. Most of CONMED's value examination focuses on studying past and present price action to predict the probability of CONMED's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CONMED's price. Additionally, you may evaluate how the addition of CONMED to your portfolios can decrease your overall portfolio volatility.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Stocks Directory Find actively traded stocks across global markets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |